| Date Filed | Type | Description |
| 10/06/2023 |
4
| Romano Sarah (CFO) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Sold 1,676 shares
@ $0.29, valued at
$486 |
|
| 07/05/2023 |
4
| Romano Sarah (CFO) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Sold 1,977 shares
@ $1.54, valued at
$3k
|
|
| 04/05/2023 |
4
| Romano Sarah (CFO) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Sold 1,975 shares
@ $2.5, valued at
$4.9k
|
|
| 01/05/2023 |
4
| Romano Sarah (CFO) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 150,000 shares
@ $0 |
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2022 |
4
| Romano Sarah (CFO) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 114 shares
@ $1.08, valued at
$123.1 |
|
| 12/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Romano Sarah (CFO) has filed a Form 4 on EYEGATE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 83 shares
@ $1.98, valued at
$164.3 |
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Romano Sarah (CFO) has filed a Form 4 on EYEGATE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 87 shares
@ $2.4, valued at
$208.8 |
|
| 07/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2020 |
4
| Romano Sarah (CFO) has filed a Form 4 on EYEGATE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 91 shares
@ $3.76, valued at
$342.2 |
|
| 11/03/2020 |
4
| Romano Sarah (CFO) has filed a Form 4 on EYEGATE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 97 shares
@ $3.51, valued at
$340.5 |
|
| 10/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2020 |
4
| Romano Sarah (CFO) has filed a Form 4 on EYEGATE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 97 shares
@ $3.94, valued at
$382.2 |
|
| 08/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2020 |
4
| Romano Sarah (CFO) has filed a Form 4 on EYEGATE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 94 shares
@ $5.11, valued at
$480.3 |
|
| 05/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2020 |
4
| Romano Sarah (CFO) has filed a Form 4 on EYEGATE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 122 shares
@ $4.97, valued at
$606.3 |
|
| 03/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2020 |
4
| Romano Sarah (CFO) has filed a Form 4 on EYEGATE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 109 shares
@ $6, valued at
$654 |
|
| 01/06/2020 |
4
| Romano Sarah (CFO) has filed a Form 4 on EYEGATE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 119 shares
@ $9.52, valued at
$1.1k
|
|
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|